Detalhe da pesquisa
1.
Safety and Immunogenicity of Accelerated Heterologous Two-dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.
Clin Infect Dis
; 2024 Apr 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38657084
2.
Predictors of All-Cause Mortality Among People With Human Immunodeficiency Virus (HIV) in a Prospective Cohort Study in East Africa and Nigeria.
Clin Infect Dis
; 75(4): 657-664, 2022 09 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34864933
3.
HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing.
Viruses
; 15(11)2023 Oct 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38005849
4.
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
Lancet Infect Dis
; 23(12): 1408-1417, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37544326
5.
Developing capacity for implementation and evaluation of vaccine trials in Uganda: Perspective of the Makerere University Walter Reed Project.
Afr Health Sci
; 22(Spec Issue): 34-41, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36321118
6.
Vaccine Licensure in the Absence of Human Efficacy Data.
Vaccines (Basel)
; 10(3)2022 Feb 26.
Artigo
Inglês
| MEDLINE | ID: mdl-35335000
7.
Assessment of tuberculosis disease activity in people infected with Mycobacterium tuberculosis and living with HIV: A longitudinal cohort study.
EClinicalMedicine
; 49: 101470, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35873194
8.
Developing capacity for implementation and evaluation of vaccine trials in Uganda: Perspective of the Makerere University Walter Reed Project
Afr. health sci. (Online)
; 22(2 Special Issue: Makerere@100): 34-41, 2022. Pictures
Artigo
Inglês
| AIM | ID: biblio-1400971